A Natural History of Disease Framework for Improving the Prevention, Management, and Research on Post-viral Fatigue Syndrome and Other Forms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

被引:7
作者
O'Boyle, Shennae [1 ,2 ]
Nacul, Luis [1 ,3 ]
Nacul, Flavio E. [4 ,5 ]
Mudie, Kathleen [1 ]
Kingdon, Caroline C. [1 ]
Cliff, Jacqueline M. [1 ]
Clark, Taane G. [1 ,6 ]
Dockrell, Hazel M. [1 ]
Lacerda, Eliana M. [1 ]
机构
[1] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England
[2] UK Hlth Secur Agcy, London, England
[3] BC Womens Hosp & Hlth Ctr, Vancouver, BC, Canada
[4] Univ Fed Rio de Janeiro, Procardiaco Hosp, Rio De Janeiro, Brazil
[5] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
[6] London Sch Hyg & Trop Med, Fac Epidmiol & Populat Hlth, London, England
基金
美国国家卫生研究院;
关键词
myalgic encephalomyelitis; chronic fatigue syndrome; ME; CFS; post-viral fatigue syndrome; chronic illness; management; research; INFECTIOUS-MONONUCLEOSIS; QUATERNARY PREVENTION; ABNORMALITIES; CONSEQUENCES; SUBTYPES; STRESS; BRAIN; NEED;
D O I
10.3389/fmed.2021.688159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We propose a framework for the treatment, rehabilitation, and research into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using a natural history of disease approach to outline the distinct disease stages, with an emphasis on cases following infection to provide insights into prevention. Moving away from the method of subtyping patients based on the various phenotypic presentations and instead reframing along the lines of disease progression could help with defining the distinct stages of disease, each of which would benefit from large prospective cohort studies to accurately describe the pathological mechanisms taking place therein. With a better understanding of these mechanisms, management and research can be tailored specifically for each disease stage. Pre-disease and early disease stages call for management strategies that may decrease the risk of long-term morbidity, by focusing on avoidance of further insults, adequate rest to enable recovery, and pacing of activities. Later disease stages require a more holistic and tailored management approach, with treatment-as this becomes available-targeting the alleviation of symptoms and multi-systemic dysfunction. More stringent and standardised use of case definitions in research is critical to improve generalisability of results and to create the strong evidence-based policies for management that are currently lacking in ME/CFS.
引用
收藏
页数:11
相关论文
共 111 条
  • [1] Comorbid clinical conditions in chronic fatigue - A co-twin control study
    Aaron, LA
    Herrell, R
    Ashton, S
    Belcourt, M
    Schmaling, K
    Goldberg, J
    Buchwald, D
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (01) : 24 - 31
  • [2] Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation
    Albrecht, Daniel S.
    Forsberg, Anton
    Sandstrom, Angelica
    Bergan, Courtney
    Kadetoff, Diana
    Protsenko, Ekaterina
    Lampa, Jon
    Lee, Yvonne C.
    Hoglund, Caroline Olgart
    Catana, Ciprian
    Cervenka, Simon
    Akeju, Oluwaseun
    Lekander, Mats
    Cohen, George
    Halldin, Christer
    Taylor, Norman
    Kim, Minhae
    Hooker, Jacob M.
    Edwards, Robert R.
    Napadow, Vitaly
    Kosek, Eva
    Loggia, Marco L.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2019, 75 : 72 - 83
  • [3] Evidence for a heritable predisposition to Chronic Fatigue Syndrome
    Albright, Frederick
    Light, Kathleen
    Light, Alan
    Bateman, Lucinda
    Cannon-Albright, Lisa A.
    [J]. BMC NEUROLOGY, 2011, 11
  • [4] Complementary and alternative medicine for patients with chronic fatigue syndrome: A systematic review
    Alraek, Terje
    Lee, Myeong Soo
    Choi, Tae-Young
    Cao, Huijuan
    Liu, Jianping
    [J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 11
  • [5] From doctors as patients: a manifesto for tackling persisting symptoms of covid-19
    Alwan, Nisreen A.
    Attree, Emily
    Blair, Jennifer Mary
    Bogaert, Debby
    Bowen, Mary-Ann
    Boyle, John
    Bradman, Madeleine
    Briggs, Tracy Ann
    Burns, Sarah
    Campion, Daniel
    Cushing, Katherine
    Delaney, Brendan
    Dixon, Chris
    Dolman, Grace E.
    Dynan, Caitriona
    Frayling, Ian M.
    Freeman-Romilly, Nell
    Hammond, Iulia
    Judge, Jenny
    Jarte, Linn
    Lokugamage, Amali
    MacDermott, Nathalie
    MacKinnon, Mairi
    Majithia, Visita
    Northridge, Tanya
    Powell, Laura
    Rayner, Clare
    Read, Ginevra
    Sahu, Ekta
    Shand, Claudia
    Small, Amy
    Strachan, Cara
    Suett, Jake
    Sykes, Becky
    Taylor, Sharon
    Thomas, Kevin
    Thomson, Margarita
    Wiltshire, Alexis
    Woods, Victoria
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [6] Long COVID: understanding the neurological effects
    不详
    [J]. LANCET NEUROLOGY, 2021, 20 (04) : 247 - 247
  • [7] Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012
    Bakken, Inger Johanne
    Tveito, Kari
    Gunnes, Nina
    Ghaderi, Sara
    Stoltenberg, Camilla
    Trogstad, Lill
    Haberg, Siri Eldevik
    Magnus, Per
    [J]. BMC MEDICINE, 2014, 12
  • [8] Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
    Balinas, Cassandra
    Cabanas, Helene
    Staines, Donald
    Marshall-Gradisnik, Sonya
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [9] Overcoming the barriers to the diagnosis and management of chronic fatigue syndrome/ME in primary care: a meta synthesis of qualitative studies
    Bayliss, Kerin
    Goodall, Mark
    Chisholm, Anna
    Fordham, Beth
    Chew-Graham, Carolyn
    Riste, Lisa
    Fisher, Louise
    Lovell, Karina
    Peters, Sarah
    Wearden, Alison
    [J]. BMC FAMILY PRACTICE, 2014, 15
  • [10] Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome
    Beaumont, Alison
    Burton, Alexander R.
    Lemon, Jim
    Bennett, Barbara K.
    Lloyd, Andrew
    Vollmer-Conna, Ute
    [J]. PLOS ONE, 2012, 7 (11):